• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Recent Trends in PSA Testing and Prostate Cancer Incidence: A Look at Context.

作者信息

Etzioni Ruth, Gulati Roman

机构信息

Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington.

出版信息

JAMA Oncol. 2016 Jul 1;2(7):955-6. doi: 10.1001/jamaoncol.2015.6310.

DOI:10.1001/jamaoncol.2015.6310
PMID:27010657
Abstract
摘要

相似文献

1
Recent Trends in PSA Testing and Prostate Cancer Incidence: A Look at Context.前列腺特异性抗原检测与前列腺癌发病率的近期趋势:背景审视
JAMA Oncol. 2016 Jul 1;2(7):955-6. doi: 10.1001/jamaoncol.2015.6310.
2
Early-stage prostate cancer, PSA screening rates decline.早期前列腺癌,前列腺特异抗原筛查率下降。
Cancer. 2016 Mar 15;122(6):825. doi: 10.1002/cncr.29930.
3
[PSA screening--medically useful or superfluous?].[前列腺特异性抗原筛查——对医学有益还是多余?]
Dtsch Med Wochenschr. 2010 Jan;135(4):p3. doi: 10.1055/s-0030-1247667. Epub 2010 Jan 25.
4
[Clinical value of prostate specific antigen screening in early detection of prostate cancer].前列腺特异性抗原筛查在前列腺癌早期检测中的临床价值
Zhonghua Zhong Liu Za Zhi. 2009 Sep;31(9):705-9.
5
The case for prostate cancer screening.前列腺癌筛查的理由。
Semin Urol. 1993 May;11(2):50-3.
6
PSA: Please Stop Agonizing (over prostate-specific antigen interpretation).
Mayo Clin Proc. 2013 Jan;88(1):1-3. doi: 10.1016/j.mayocp.2012.11.004.
7
Longitudinal screening for prostate cancer with prostate-specific antigen.使用前列腺特异性抗原对前列腺癌进行纵向筛查。
JAMA. 1996;276(16):1309-15.
8
Prostate cancer and prostate-specific antigen (PSA) screening in Austria.奥地利的前列腺癌与前列腺特异性抗原(PSA)筛查
Wien Klin Wochenschr. 2005 Jul;117(13-14):457-61. doi: 10.1007/s00508-005-0395-y.
9
The role of PSA and percent free PSA for staging and prognosis prediction in clinically localized prostate cancer.前列腺特异性抗原(PSA)和游离PSA百分比在临床局限性前列腺癌分期及预后预测中的作用。
Semin Urol Oncol. 1998 Aug;16(3):100-5.
10
Recommended prostate-specific antigen testing intervals for the detection of curable prostate cancer.用于检测可治愈前列腺癌的推荐前列腺特异性抗原检测间隔时间。
JAMA. 1997 May 14;277(18):1456-60.

引用本文的文献

1
Combination of PSA density and MLR improves the diagnostic accuracy of prostate cancer.前列腺特异抗原密度(PSA density)与肌层浸润率(MLR)相结合可提高前列腺癌的诊断准确性。
Front Oncol. 2025 Jul 16;15:1570584. doi: 10.3389/fonc.2025.1570584. eCollection 2025.
2
Treatment trends in patients with de novo metastatic prostate cancer in the era of upfront combination therapy.初始联合治疗时代新发转移性前列腺癌患者的治疗趋势
Int J Urol. 2024 Dec;31(12):1330-1336. doi: 10.1111/iju.15550. Epub 2024 Aug 23.
3
Increasing aggressive prostate cancer.
侵袭性前列腺癌增多。
Can J Urol. 2022 Dec;29(6):11384-11390.
4
Variations in Age-Adjusted Prostate Cancer Incidence Rates by Race and Ethnicity After Changes in Prostate-Specific Antigen Screening Recommendation.种族和民族在前列腺特异性抗原筛查建议改变后,年龄调整前列腺癌发病率的变化。
JAMA Netw Open. 2022 Nov 1;5(11):e2240657. doi: 10.1001/jamanetworkopen.2022.40657.
5
Prostate-Specific Antigen Screening and Recent Increases in Advanced Prostate Cancer.前列腺特异性抗原筛查与近期高级别前列腺癌的增加。
JNCI Cancer Spectr. 2020 Oct 26;5(1). doi: 10.1093/jncics/pkaa098. eCollection 2021 Feb.
6
A Trend Toward Aggressive Prostate Cancer.侵袭性前列腺癌的一种趋势。
Rev Urol. 2020;22(3):102-109.
7
An Up-to-date Assessment of US Prostate Cancer Incidence Rates by Stage and Race: A Novel Approach Combining Multiple Imputation with Age and Delay Adjustment.基于年龄和延迟调整的多项插补法对美国按阶段和种族划分的前列腺癌发病率的最新评估:一种新方法。
Eur Urol. 2021 Jan;79(1):33-41. doi: 10.1016/j.eururo.2020.09.041. Epub 2020 Oct 20.
8
Prostate Biopsy Features: A Comparison Between the Pre- and Post-2012 United States Preventive Services Task Force Prostate Cancer Screening Guidelines With Emphasis on African American and Septuagenarian Men.前列腺活检特征:2012年美国预防服务工作组前列腺癌筛查指南前后对比,重点关注非裔美国人和七十岁男性。
Rev Urol. 2019;21(1):1-7.
9
Prostate Biopsy Characteristics: A Comparison Between the Pre- and Post-2012 United States Preventive Services Task Force (USPSTF) Prostate Cancer Screening Guidelines.前列腺活检特征:2012年美国预防服务工作组(USPSTF)前列腺癌筛查指南前后对比
Rev Urol. 2018;20(2):77-83. doi: 10.3909/riu0793.
10
Impact of United States Preventive Services Task Force recommendations on prostate biopsy characteristics and disease presentation at a tertiary-care medical center.美国预防服务工作组建议对一家三级医疗中心前列腺活检特征及疾病表现的影响
Prostate Int. 2018 Sep;6(3):110-114. doi: 10.1016/j.prnil.2018.03.001. Epub 2018 Mar 9.